Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Costunolide helps human hair cells grow and can stimulate hair growth in mice.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Fumaric acid esters might help treat alopecia areata, but more research is needed.

PRP treatment may help with alopecia areata, especially in newer cases.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

A woman with multiple autoimmune diseases showed improvement in hair loss but not in skin discoloration after treatment.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

JAK inhibitors offer new hope for treating severe alopecia areata.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.